0.68  0.01 (1.49%)		01-23 16:00
Open: 0.6735 High: 0.6983 Volume: 122,682		Pre. Close: 0.67 Low: 0.6601 Market Cap: 14(M)

Short term
Mid term
Targets	6-month :	0.84	1-year :	0.9
Resists	First :	0.72	Second :	0.77
Pivot price	0.68
Supports	First :	0.64	Second :	0.53
MAs	MA(5) :	0.67	MA(20) :	0.68
	MA(100) :	0.85	MA(250) :	1.21
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	25.7	D(3) :	20.9
RSI	RSI(14): 45.6
52-week	High :	1.9	Low :	0.63

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ COCH ] has closed above bottom band by 43.9%. Bollinger Bands are 82.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.7 - 0.7	0.7 - 0.7
Low:	0.65 - 0.66	0.66 - 0.66
Close:	0.67 - 0.68	0.68 - 0.68

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Fri, 19 Dec 2025
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant - Florida Hospital News and Healthcare Report

Wed, 03 Dec 2025
Envoy Medical, Inc. (COCH) Upgraded to Buy: Here's Why - Yahoo Finance

Tue, 18 Nov 2025
Envoy Medical (NASDAQ: COCH) completes first 10-patient, 6-month Acclaim implant milestone - Stock Titan

Mon, 10 Nov 2025
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Thu, 06 Nov 2025
Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy? - Nasdaq

Tue, 04 Nov 2025
Envoy Medical (NASDAQ: COCH) enrolls first 3 of 46 in final-stage Acclaim cochlear trial - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	29 (M)
Held by Insiders	1.811e+007 (%)
Held by Institutions	37 (%)
Shares Short	707 (K)
Shares Short P.Month	0 (K)

EPS	-2.016e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-13 %
Return on Assets (ttm)	590.4 %
Return on Equity (ttm)	-145.4 %
Qtrly Rev. Growth	208000 %
Gross Profit (p.s.)	-11.97
Sales Per Share	0
EBITDA (p.s.)	-292823
Qtrly Earnings Growth	-1.4 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-18 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-4.45

Dividend	0
Forward Dividend	480940
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.